EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients

Andrew J Franck, Andrew L Hendrickson, Evan D Telford, BreAnna L Davids, Irina Murray Casanova, Abbie N Rosen, Susheela Hadigal, Robert C Ross

CHEST · 2025-08 · 168 (2) · 326-335

DOI: 10.1016/j.chest.2025.02.006 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift CHEST, 2025-08. Verfasst von Andrew J Franck und 7 weiteren Autor:innen. Beteiligte Einrichtung: North Florida/South Georgia Veterans Health System, Gainesville, FL. Electronic address: Andrew.Franck@va.gov. Hauptthemen laut MEDLINE: Hyperglycemia, Critical Illness, Blood Glucose. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Dexcom Inc, U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Continuous glucose monitors (CGMs) could potentially improve management of hyperglycemia compared with standard point-of-care glucose monitoring for critically ill patients. However, there is limited evidence to support routine use of CGMs in the ICU. RESEARCH QUESTION: In critically ill patients with hyperglycemia, do CGMs improve time within target glucose range compared with standard of care? STUDY DESIGN AND METHODS: This was an investigator-initiated, single-center, parallel-group, open-label, randomized controlled trial. Adult patients admitted to a medical or surgical ICU who had diabetes mellitus or hyperglycemia and were treated with insulin were eligible for enrollment. Participants were randomly assigned to have glucose monitoring performed with a CGM (intervention group) or standard of care (control group). Groups were compared for glycemic control and other relevant outcomes. The primary outcome for the study was percentage of time within the normoglycemic range, defined as 70 to 180 mg/dL (3.9-10 mmol/L). RESULTS: Eighty-five participants were enrolled and randomized to study groups, with 43 participants in the intervention (CGM) group and 42 patients in the control (standard of care) group. For the primary outcome, there was no statistically significant difference between the intervention group (mean ± SD, 60.5% ± 30.5%) and the control group (mean ± SD, 61.4% ± 28.3%) in time within the goal glucose range (mean difference, -0.9%; 95% CI, -13.6 to 11.8; P = .9). Except for patient satisfaction, there were no statistically significant differences between groups for secondary and exploratory outcomes. INTERPRETATION: The results of this study do not support CGMs as a superior method for routine glucose monitoring in the ICU compared with standard of care. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT05442853; URL: www. CLINICALTRIALS: gov.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperglycemiaCritical IllnessBlood GlucoseHumansFemaleMaleMiddle AgedMonitoring, PhysiologicAgedIntensive Care UnitsInsulinCritical CareContinuous Glucose Monitoring

Stichwörter der Autor:innen

continuous glucose monitorsdiabetes mellitushyperglycemiaintensive care

Substanzen

Blood GlucoseInsulin

Autor:innen und Institutionen

  • North Florida/South Georgia Veterans Health System, Gainesville, FL. Electronic address: Andrew.Franck@va.gov.
  • North Florida/South Georgia Veterans Health System, Gainesville, FL.
  • Ralph H. Johnson Veterans Affairs Health Care System, Charleston, SC.
  • North Florida/South Georgia Veterans Health System, Gainesville, FL; Division of Acute Care Surgery, Department of Surgery, Gainesville, FL.
  • North Florida/South Georgia Veterans Health System, Gainesville, FL; Division of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL.
  • G.V. (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, MS.

Förderung

  • Dexcom Inc
  • U.S. Department of Veterans Affairs

Zitieren

APA

Franck, A. J., Hendrickson, A. L., Telford, E. D., Davids, B. L., Murray Casanova, I., Rosen, A. N., Hadigal, S., & Ross, R. C. (2025). Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients. CHEST, 168(2), 326-335. https://doi.org/10.1016/j.chest.2025.02.006

Vancouver

Franck AJ, Hendrickson AL, Telford ED, Davids BL, Murray Casanova I, Rosen AN, et al. Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients. CHEST. 2025;168(2):326-335. doi:10.1016/j.chest.2025.02.006

BibTeX
@article{Franck2025,
  author = {Franck, Andrew J and Hendrickson, Andrew L and Telford, Evan D and Davids, BreAnna L and Murray Casanova, Irina and Rosen, Abbie N and Hadigal, Susheela and Ross, Robert C},
  title = {Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients},
  journal = {CHEST},
  year = {2025},
  volume = {168},
  number = {2},
  pages = {326--335},
  doi = {10.1016/j.chest.2025.02.006}
}
Kostenlos starten →